PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan. Electronic address: nao_taniyan@icloud.com.\', \'Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.\', \'Pharmacy, Fukuoka City Hospital, Fukuoka, Japan.\', \'Clinical Laboratory, Fukuoka City Hospital, Fukuoka, Japan.\', \'Department of Infectious Diseases, Fukuoka City Hospital, Fukuoka, Japan.\', \'Department of Neurology, Fukuoka City Hospital, Fukuoka, Japan.\', \'Center for the Study of Global Infection, Kyushu University Hospital, Fukuoka, Japan.\', \'Ricerca Clinica Co., Fukuoka, Japan.\', \'Fukuoka City Hospital, Fukuoka, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(22)00158-X10.1016/j.vaccine.2022.02.025
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 35177298
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccine.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all